[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"glasgow-blatchford-score\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:glasgow-blatchford-score":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":5},"100599806","external-validation-of-the-glasgow-blatchford-bleeding-score-in-a-tunisian-population-100599806",false,"NCT07089277","External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population","Inclusion Criteria:\n\n* Adult patients (≥18 years) presenting with non-traumatic upper gastrointestinal bleeding\n\nExclusion Criteria:\n\n* patients under 18 years of age.\n\nDiagnosis of external hemorrhoids with mucosal lesions.\n\nPatients who do not consent, are lost to follow-up, or have incomplete data.","ALL","18 Years",{"count":18,"type":19},250,"ESTIMATED","OBSERVATIONAL","This study aims to externally validate the Glasgow-Blatchford Score (GBS) in a Tunisian population presenting with non-traumatic upper gastrointestinal bleeding. Despite advances in endoscopic management, early risk stratification remains essential to guide clinical decision-making. In Tunisia, the routine hospitalization of all patients for observation presents a challenge, highlighting the need for reliable prognostic tools.\n\nThe study is designed as a multicenter, descriptive, and analytical investigation across several emergency departments. Adult patients (≥16 years) will be included, with follow-up conducted at 30 days to assess for adverse outcomes including rebleeding, the need for hemostasis, complications, and mortality.\n\nClinical and epidemiological data will be collected using a standardized form. Statistical analysis will evaluate the predictive performance of the GBS, focusing on sensitivity, specificity, and predictive values for 30-day outcomes.\n\nThe results are expected to determine whether GBS is a valid and useful tool for risk assessment in the Tunisian context, potentially aiding in more efficient and targeted patient management.",[23,24],"Upper Gastrointestinal Bleeding (UGIB)","Glasgow-Blatchford Score","RECRUITING","2025-07-21",{"date":28,"type":29},"2025-07-28","ACTUAL",{"date":31,"type":29},"2024-01-01",{"date":33,"type":19},"2025-12-30",{"name":35,"class":36},"Hôpital Universitaire Sahloul","OTHER"]